Phlox Therapeutics
Naarden, NL · 2 known investors
Phlox Therapeutics develops RNA-based precision genetic medicines and gene therapies to treat and potentially cure rare genetic heart diseases such as cardiomyopathies and laminopathies. The company targets the underlying causes of genetic cardiac dysfunction for patients underserved by current standard of care.
BiotechHealthtech
Investors · 2
Frequently asked questions
- What does Phlox Therapeutics do?
- Phlox Therapeutics develops RNA-based precision genetic medicines and gene therapies to treat and potentially cure rare genetic heart diseases such as cardiomyopathies and laminopathies. The company targets the underlying causes of genetic cardiac dysfunction for patients underserved by current standard of care.
- Who are Phlox Therapeutics's investors?
- Phlox Therapeutics's investors include ROM Utrecht Region, UvA Ventures Holding.
- Where is Phlox Therapeutics headquartered?
- Phlox Therapeutics is headquartered in Naarden, NL.